The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States

Kiatpongsan, Sorapop; Huckman, Robert S.; Hornstein, Mark D.

doi:10.1016/j.fertnstert.2014.10.042

Cited by 8 publications

(5 citation statements)

References 16 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of assisted reproductive technologies (ART) has risen steadily in the United States since the first in vitro fertilization (IVF) birth in 1981 due to several reasons, including childbearing at older maternal ages and increasing insurance coverage and availability of infertility treatments [1][2][3][4]. The number of ART cycles in the United States has more than tripled in the most recent 20-year period between 1997 and 2017 (from 71,826 to 248,385 cycles per year [196,850 with intent to transfer]), and currently 2.0% of all live births in the United States are the result of this technology [5][6][7][8].…”

Section: Introductionmentioning

confidence: 99%

In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters

Luke

Brown

Callan

et al. 2020

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Introductionmentioning

confidence: 99%

In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters

Luke

Brown

Callan

et al. 2020

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

show abstract

“…Studies are mixed on whether intracytoplasmic sperm injection (ICSI) is superior to conventional IVF with respect to ART pregnancy and live birth outcomes [14–17]. However, access to ICSI versus conventional IVF varies widely and is dependent upon individual medical insurance policy, federal legislation and state regulations [18–22]. …”

Section: Introductionmentioning

confidence: 99%

Differences in utilization of Intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S.

Zagadailov

Hsu

Seifer

et al. 2017

Reprod Biol Endocrinol

View full text Add to dashboard Cite

BackgroundAnecdotal evidence suggests that US practice patterns for ART differ by geographical region. The purpose of this study was to determine whether use of ICSI differs by region and to evaluate whether these rates are correlated with differences in live birth rates.MethodsPublic data for 2012 were obtained from the Centers for Disease Control and Prevention. Clinics with ≥100 fresh, non-donor cycles were grouped by 10 nationally recognized Department of Health & Human Services regions and 11 metropolitan Megaregions and were compared for use of ICSI, frequency of male factor infertility, and live birth rate in women <35 years.ResultsThere were 274 clinics in the Health & Human Services regions and 247 in the Megaregions. ICSI utilization rates in Health & Human Services groups ranged between 52.5–78.2% (P < 0.0001). Live birth rates per cycle in women <35 years differed (34.1–47.6%; P < 0.0001) but did not correlate with rates of ICSI (R2 = 0.2096; P = 0.18) per cycle. For Megaregions, rates of ICSI per cycle differed (63.4%–93.5%, P < 0.0001) as did live birth rates per cycle for women <35 (36.0%–59.0%, P = 0.001) but there was only minimal correlation between them (R2 = 0.5347; P = 0.01). Highest rates of ICSI occurred in Front Range (93.5%) and Gulf Coast (83.1%) Megaregions. Lowest rates occurred in the Northeast (63.4%) and Florida (64.8%) Megaregions. Male factor infertility rates did not differ across regions.ConclusionsICSI utilization and live birth rates per cycle for each clinic group were significantly different across geographical regions of the U.S. However, higher ICSI utilization rate was not associated with higher rates of male factor infertility nor were they strongly correlated with higher live birth rates per cycle. Studies are needed to understand factors that may influence ICSI overutilization in the U.S.

show abstract

“…Marina Cadena Matta, PhD, 1 Alexandre de Freitas Cavalcanti Filho, MS, 1 Leuridan Cavalcante Torres, Sr., PhD, 1 Peter N. Schlegel, M.D., 2 Shuibing Chen, PhD, 2 Gilbert J. Wise, MD.…”

Section: Zika Virus Infection and Male Fertility Two Years After A Major Outbreak: Prelim-inary Findings Filipe Tenorio Lira Neto MD Mscmentioning

confidence: 99%

Descriptive Differences in Fertility Treatment Usage After the Start of the Covid-19 Pandemic: A Pilot Study - Feelings About Infertility in Response to the Covid-19 Epidemic (Fire)

Iko

Adeleye

Zamah

2020

Fertility and Sterility

View full text Add to dashboard Cite

The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States

Cited by 8 publications

References 16 publications

In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters

In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters

Differences in utilization of Intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S.

Descriptive Differences in Fertility Treatment Usage After the Start of the Covid-19 Pandemic: A Pilot Study - Feelings About Infertility in Response to the Covid-19 Epidemic (Fire)

Contact Info

Product

Resources

About